Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso

Autores:
Benavides, Javier Mauricio
Vivas, Jhon Jairo
Jaramillo, Gilberto
Bernal, Wilker
Tipo de recurso:
Article of journal
Fecha de publicación:
2017
Institución:
Fundación Universitaria de Ciencias de la Salud - FUCS
Repositorio:
Repositorio Digital Institucional ReDi
Idioma:
spa
OAI Identifier:
oai:repositorio.fucsalud.edu.co:001/1999
Acceso en línea:
https://repositorio.fucsalud.edu.co/handle/001/1999
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/18
Palabra clave:
Trombosis venosa profunda
Hipertiroidismo
Coagulación
Factor VIII
Deep venous thrombosis
Hyperthyroidism
Coagulation
Factor VIII
Rights
openAccess
License
Fundación Universitaria de Ciencias de la Salud-FUCS - 2017
id FUCS2_8cdf7fa9fbb1d18a8edf76d842b1e686
oai_identifier_str oai:repositorio.fucsalud.edu.co:001/1999
network_acronym_str FUCS2
network_name_str Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso
dc.title.translated.eng.fl_str_mv A case of deep venous thrombosis in a patient with de novo hyperthyroidism
title Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso
spellingShingle Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso
Trombosis venosa profunda
Hipertiroidismo
Coagulación
Factor VIII
Deep venous thrombosis
Hyperthyroidism
Coagulation
Factor VIII
title_short Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso
title_full Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso
title_fullStr Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso
title_full_unstemmed Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso
title_sort Trombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de caso
dc.creator.fl_str_mv Benavides, Javier Mauricio
Vivas, Jhon Jairo
Jaramillo, Gilberto
Bernal, Wilker
dc.contributor.author.spa.fl_str_mv Benavides, Javier Mauricio
Vivas, Jhon Jairo
Jaramillo, Gilberto
Bernal, Wilker
dc.subject.spa.fl_str_mv Trombosis venosa profunda
Hipertiroidismo
Coagulación
Factor VIII
topic Trombosis venosa profunda
Hipertiroidismo
Coagulación
Factor VIII
Deep venous thrombosis
Hyperthyroidism
Coagulation
Factor VIII
dc.subject.eng.fl_str_mv Deep venous thrombosis
Hyperthyroidism
Coagulation
Factor VIII
publishDate 2017
dc.date.accessioned.none.fl_str_mv 2017-03-01 00:00:00
2022-02-21T20:33:06Z
dc.date.issued.none.fl_str_mv 2017-03-01
dc.date.available.none.fl_str_mv 2017-03-01 00:00:00
2022-02-21T20:33:06Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.eng.fl_str_mv Journal article
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 0121-7372
dc.identifier.uri.none.fl_str_mv https://repositorio.fucsalud.edu.co/handle/001/1999
dc.identifier.eissn.none.fl_str_mv 2462-991X
dc.identifier.url.none.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/18
identifier_str_mv 0121-7372
2462-991X
url https://repositorio.fucsalud.edu.co/handle/001/1999
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/18
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Vaya A, Mira Y, Martinez M, Villa P, Ferrando F, Estelles A, et al. Biological risk factors for deep vein thrombosis. Clin Hemorheol Microcirc. 2002;26:41–53.
Alotaibi GS, Wu C, Senthilselvan A, McMurtry MS. Secular trends in incidence and mortality of acute venous thromboembolism: The AB-VTE Population-Based Study. Am J Med. 2016.
Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28:370–2.
Vázquez FJ, Posadas-Martínez ML, Vicens J, de Quirós FGB, Giunta DH. Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: A prospective cohort. Thromb J. 2013;11:1.
Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism a statement for healthcare professionals from the Council on Thrombosis (in Consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation. 1996;93: 2212–45.
White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107 23 Suppl 1:I4–8.
Squizzato A, Romualdi E, Büller HR, Gerdes VEA. Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic review. J Clin Endocrinol Metab. 2007;92: 2415–20.
Erem C, Ersoz H, Karti SS, Ukinc K, Hacihasanoglu A, Değer O, et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest. 2002;25:345–50.
Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med. 1982;97:713–6.
Burggraaf J, Lalezari S, Emeis JJ, Vischer UM, de Meyer P, Pijl H, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid. 2001;11:153–60.
Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab. 2007;92:3006–12.
Van Zaane B, Squizzato A, Huijgen R, van Zanten AP, Fliers E, Cannegieter SC, et al. Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: A case-control study. Blood. 2010;115:4344–9.
Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. Eur J Endocrinol. 1997;136:1–7.
Lin HC, Yang LY, Kang JH. Increased risk of pulmonary embolism among patients with hyperthyroidism: A 5-year follow-up study. J Thromb Haemost. 2010;8:2176–81.
Rengifo HM. Hipertiroidismo. En: Sociedad Colombiana de Endocrinología. Fascículo tiroides [Internet]. 2011 [revisado 28 Sep 2016]. Disponible en: http://www.endocrino.org.co/wp-content/uploads/2015/12/Hipertiroidismo.pdf
Maes J, Michotte A, Velkeniers B, Stadnik T, Jochmans K. Hyperthyroidism with increased factor VIII procoagulant protein as a predisposing factor for cerebral venous thrombosis. J Neurol Neurosurg Psychiatry. 2002;73:458.
Franchini M, Lippi G, Targher G. Hyperthyroidism, venous thrombosis: a casual or causal association? A systematic literature review. Clin Appl Thromb Hemost. 2011;17: 387–92.
Debeij J, Dekkers OM, Asvold BO, Christiansen SC, Naess IA, Hammerstrom J, et al. Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study. J Thromb Haemost. 2012;10:1539–46.
Debeij J, Cannegieter SC, van Zaane B, Smit JWA, Corssmit EPM, Rosendaal FR, et al. The effect of changes in thyroxine and thyroid-stimulating hormone levels on the coagulation system. J Thromb Haemost. 2010;8:2823–6.
Stuijver DJF, van Zaane B, Romualdi E, Brandjes DPM, Gerdes VEA, Squizzato A. The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors. Thromb Haemost. 2012;108:1077–88.
Lippi G, Franchini M, Targher G, Montagnana M, Salvagno GL, Guidi GC, et al. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients. J Thromb Thrombolysis. 2009;28:362–5.
Van Zaane B, Squizzato A, Debeij J, Dekkers OM, Meijers JCM, van Zanten AP, et al. Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: A controlled randomized crossover study. J Thromb Haemost. 2011;9:1816–24.
Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133 6 Suppl:454S–545S.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141 2 Suppl:e419S–24S.
Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy1. J Am Coll Cardiol. 2003;41:1633–52.
Akin F, Yaylali GF, Bastemir M, Yapar B. Effect of methimazole on warfarin anticoagulation in a case of Graves’ disease. Blood Coagul Fibrinolysis. 2008;19: 89–91.
dc.relation.bitstream.none.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/18/8
dc.relation.citationedition.spa.fl_str_mv Núm. 1 , Año 2017 : Enero - Marzo
dc.relation.citationendpage.none.fl_str_mv 49
dc.relation.citationissue.spa.fl_str_mv 1
dc.relation.citationstartpage.none.fl_str_mv 44
dc.relation.citationvolume.spa.fl_str_mv 26
dc.relation.ispartofjournal.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv Fundación Universitaria de Ciencias de la Salud-FUCS - 2017
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Fundación Universitaria de Ciencias de la Salud-FUCS - 2017
https://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/18
institution Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv https://repositorio.fucsalud.edu.co/bitstreams/3f97a6cd-8625-4cf6-8c16-4f05ec2824c5/download
bitstream.checksum.fl_str_mv 0ce27b1d9fe6657317f555f3948703af
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv redi@fucsalud.edu.co
_version_ 1814355542219423744
spelling Benavides, Javier Mauricio295ac647347942635e3d59346473ca1b500Vivas, Jhon Jairodaa810f22862bd8ff2566b63bc059eea300Jaramillo, Gilberto4216aa1052d989bfb32779d8fc129995500Bernal, Wilkerb906341792e1201cf0c4ba8438feeb8f3002017-03-01 00:00:002022-02-21T20:33:06Z2017-03-012017-03-01 00:00:002022-02-21T20:33:06ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud-FUCS - 2017info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/18Trombosis venosa profundaHipertiroidismoCoagulaciónFactor VIIIDeep venous thrombosisHyperthyroidismCoagulationFactor VIIITrombosis venosa profunda en un paciente con hipertiroidismo de novo. Presentación de casoA case of deep venous thrombosis in a patient with de novo hyperthyroidismapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a850121-7372https://repositorio.fucsalud.edu.co/handle/001/19992462-991Xhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/18spaVaya A, Mira Y, Martinez M, Villa P, Ferrando F, Estelles A, et al. Biological risk factors for deep vein thrombosis. Clin Hemorheol Microcirc. 2002;26:41–53.Alotaibi GS, Wu C, Senthilselvan A, McMurtry MS. Secular trends in incidence and mortality of acute venous thromboembolism: The AB-VTE Population-Based Study. Am J Med. 2016.Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28:370–2.Vázquez FJ, Posadas-Martínez ML, Vicens J, de Quirós FGB, Giunta DH. Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: A prospective cohort. Thromb J. 2013;11:1.Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism a statement for healthcare professionals from the Council on Thrombosis (in Consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation. 1996;93: 2212–45.White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107 23 Suppl 1:I4–8.Squizzato A, Romualdi E, Büller HR, Gerdes VEA. Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic review. J Clin Endocrinol Metab. 2007;92: 2415–20.Erem C, Ersoz H, Karti SS, Ukinc K, Hacihasanoglu A, Değer O, et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest. 2002;25:345–50.Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med. 1982;97:713–6.Burggraaf J, Lalezari S, Emeis JJ, Vischer UM, de Meyer P, Pijl H, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid. 2001;11:153–60.Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab. 2007;92:3006–12.Van Zaane B, Squizzato A, Huijgen R, van Zanten AP, Fliers E, Cannegieter SC, et al. Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: A case-control study. Blood. 2010;115:4344–9.Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. Eur J Endocrinol. 1997;136:1–7.Lin HC, Yang LY, Kang JH. Increased risk of pulmonary embolism among patients with hyperthyroidism: A 5-year follow-up study. J Thromb Haemost. 2010;8:2176–81.Rengifo HM. Hipertiroidismo. En: Sociedad Colombiana de Endocrinología. Fascículo tiroides [Internet]. 2011 [revisado 28 Sep 2016]. Disponible en: http://www.endocrino.org.co/wp-content/uploads/2015/12/Hipertiroidismo.pdfMaes J, Michotte A, Velkeniers B, Stadnik T, Jochmans K. Hyperthyroidism with increased factor VIII procoagulant protein as a predisposing factor for cerebral venous thrombosis. J Neurol Neurosurg Psychiatry. 2002;73:458.Franchini M, Lippi G, Targher G. Hyperthyroidism, venous thrombosis: a casual or causal association? A systematic literature review. Clin Appl Thromb Hemost. 2011;17: 387–92.Debeij J, Dekkers OM, Asvold BO, Christiansen SC, Naess IA, Hammerstrom J, et al. Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study. J Thromb Haemost. 2012;10:1539–46.Debeij J, Cannegieter SC, van Zaane B, Smit JWA, Corssmit EPM, Rosendaal FR, et al. The effect of changes in thyroxine and thyroid-stimulating hormone levels on the coagulation system. J Thromb Haemost. 2010;8:2823–6.Stuijver DJF, van Zaane B, Romualdi E, Brandjes DPM, Gerdes VEA, Squizzato A. The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors. Thromb Haemost. 2012;108:1077–88.Lippi G, Franchini M, Targher G, Montagnana M, Salvagno GL, Guidi GC, et al. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients. J Thromb Thrombolysis. 2009;28:362–5.Van Zaane B, Squizzato A, Debeij J, Dekkers OM, Meijers JCM, van Zanten AP, et al. Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: A controlled randomized crossover study. J Thromb Haemost. 2011;9:1816–24.Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133 6 Suppl:454S–545S.Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141 2 Suppl:e419S–24S.Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy1. J Am Coll Cardiol. 2003;41:1633–52.Akin F, Yaylali GF, Bastemir M, Yapar B. Effect of methimazole on warfarin anticoagulation in a case of Graves’ disease. Blood Coagul Fibrinolysis. 2008;19: 89–91.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/18/8Núm. 1 , Año 2017 : Enero - Marzo4914426Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2568https://repositorio.fucsalud.edu.co/bitstreams/3f97a6cd-8625-4cf6-8c16-4f05ec2824c5/download0ce27b1d9fe6657317f555f3948703afMD51001/1999oai:repositorio.fucsalud.edu.co:001/19992024-02-02 13:07:20.699https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud-FUCS - 2017metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co